Secteur Crinetics Pharmaceuticals, Inc.

Actions

CRNX

US22663K1079

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 16/07/2026 Varia. 5j. Varia. 1 janv.
83,91 USD +0,01% Graphique intraday de Crinetics Pharmaceuticals, Inc. +0,35% +80,26%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+0,01%+0,35%+139,74%+115,04%+80,26%+163,04%+311,93%+325,51% - 8,85 Md
-3,42%+4,90%+29,38%+20,20%+40,11%+61,15%+87,70%-23,08% - 55,98 Md
-0,05%-5,85%-0,74%+5,57%+4,66%+54,36%+124,61%+189,65%+5 498,51% 53,69 Md
-2,14%-9,13%+12,50%-24,74%-38,26%+2,74%+421,65%+303,08%+842,63% 23,29 Md
-0,47%-1,53%+2,30%-10,34%-3,82%-18,61%-15,41%-60,44% - 23,15 Md
-6,26%-2,90%+23,44%+3,19%+17,24%+30,25%-9,77%-73,60% - 20,58 Md
-0,29%-2,05%+21,50%+5,61%-6,73%+34,41%-27,98%-30,67%+65,54% 17,76 Md
-4,55%-1,95%+41,04%+111,77%+197,38%+192,65%+349,58%+1 656,58%+630,60% 16,09 Md
-6,49%-5,40%+21,12%-6,04%+24,58%+27,11%+647,67% - - 15,93 Md
+0,23%-2,49%+6,87%+25,46%+27,04%+24,26%+187,16%+231,43%+559,72% 14 Md
-0,86%-2,59%+8,85%+3,96%-6,32%+58,14%+141,63%+481,15% - 12,58 Md
-12,52%-8,43%+6,14%-41,03%-21,19%-36,16%+142,64%+55,41% - 11,96 Md
-8,69%-11,11%-0,86%-43,65%-21,33%-51,33%+542,99%+94,35%+82,25% 10,68 Md
-2,74%-6,63%+6,85%+22,84%+26,47%+107,76%+130,06%+317,89%+712,54% 10,91 Md
-0,62%-15,03%-6,76%+4,99%+7,51%+290,03%+106,29%+12,53%+1 128,49% 10,05 Md
-10,41%-9,45%+12,98%-36,49%+5,76%+10,44%+77,51%-28,36% - 9,42 Md
-7,79%-4,69%+12,84%+35,04%+187,30%+480,99%+573,49%-44,39%-16,71% 8,28 Md
-1,05%+2,02%+48,18%+24,96%+19,16%+26,61%+332,10%+300,32% - 8,24 Md
-1,23%-6,33%+13,65%-9,90%+21,46%+53,24%+12,89%+160,65% - 8,09 Md
-3,62%-16,01%+10,86%+2,76%+276,26%+170,91%+167,99%-31,21% - 7,8 Md
Moyenne -3,65%-2,69%+20,49%+10,46%+41,88%+84,10%+215,24%+201,94%+1 055,95% 17,37 Md
Moyenne pondérée par Capi. -3,05%-1,92%+17,69%+9,62%+29,66%+64,57%+181,64%+179,48%+2 147,80%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action CRNX
  4. Secteur Crinetics Pharmaceuticals, Inc.